In general, we not only established a high-throughput screening technology based on the SOAT1 protein and initially obtained two promising candidates for the treatment of liver cancer, but also systematically revealed that SOAT1-targeting compounds reprogram cholesterol metabolism to remedy hepatocelluar carcinoma. This evidence concerns the gene SOAT1 and carcinoma.